As the psychedelic pharmaceutical industry increasingly prioritizes personal data extraction through mobile apps, wearables, and so-called “targeted” medicine, a recent data breach by former MAPS Canada Executive Director Mark Haden provides a warning about some of the possible consequences to the financial incentives of datafication.